Literature DB >> 7726560

Characterization of glycosylphosphatidylinositol (GPI)-anchored NCAM on mouse skeletal muscle cell line C2C12: the structure of the GPI glycan and release during myogenesis.

R Mukasa1, M Umeda, T Endo, A Kobata, K Inoue.   

Abstract

The mouse myoblast cell line C2C12 constitutively expressed 160-kDa transmembrane NCAM isoform and 135-kDa GPI-anchored isoform before differentiation. During differentiation into multinucleated myotubes, the cells newly expressed 150-kDa GPI-anchored isoform and the level of 135-kDa GPI-anchored isoform increased. Structural analysis of the GPI glycan of NCAM, which was purified from C2C12 myotubes after metabolic labeling with [3H]inositol, was performed by sequential exoglycosidase digestion and Wistaria floribunda agglutinin-agarose column chromatography. The core GPI glycan structure, Man alpha 1-2Man alpha-Man alpha-GlcNH2-myoInositol, was conserved and variations were observed in additional mannose and N-acetylgalactosamine residues. Structural analysis of the GPI glycans of the two GPI-anchored isoforms, GPI-NCAM 135 and GPI-NCAM 150, showed the enhanced attachment of the N-acetylgalactosamine residue to the GPI glycan core of GPI-NCAM 150. These GPI-anchored NCAM isoforms were released from C2C12 cells during the myoblast differentiation. Release of GPI-anchored NCAMs was observed when C2C12 cells were cultured in a serum-free medium, and inositol but not inositol phosphate was detected after nitrous acid deamination of the released NCAM. These results suggest that the GPI-anchored NCAM was released from the cell surface by the action of an endogeneous phospholipase D.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7726560     DOI: 10.1006/abbi.1995.1219

Source DB:  PubMed          Journal:  Arch Biochem Biophys        ISSN: 0003-9861            Impact factor:   4.013


  8 in total

1.  Down-regulation of glycosylphosphatidylinositol-specific phospholipase D induced by lipopolysaccharide and oxidative stress in the murine monocyte- macrophage cell line RAW 264.7.

Authors:  X Du; M G Low
Journal:  Infect Immun       Date:  2001-05       Impact factor: 3.441

2.  Using differential solubilization and 2-D gel electrophoresis to visualize increased numbers of proteins in the human cortex and caudate nucleus and putamen.

Authors:  Brian Dean; Geoffrey Pavey; A Ian Smith
Journal:  Proteomics Clin Appl       Date:  2008-07-30       Impact factor: 3.494

3.  PGAP2 is essential for correct processing and stable expression of GPI-anchored proteins.

Authors:  Yuko Tashima; Ryo Taguchi; Chie Murata; Hisashi Ashida; Taroh Kinoshita; Yusuke Maeda
Journal:  Mol Biol Cell       Date:  2006-01-11       Impact factor: 4.138

4.  Distinct contributions of Galgt1 and Galgt2 to carbohydrate expression and function at the mouse neuromuscular junction.

Authors:  Neha Singhal; Rui Xu; Paul T Martin
Journal:  Mol Cell Neurosci       Date:  2012-09-07       Impact factor: 4.314

5.  Microvesicles/exosomes as potential novel biomarkers of metabolic diseases.

Authors:  Günter Müller
Journal:  Diabetes Metab Syndr Obes       Date:  2012-08-07       Impact factor: 3.168

6.  The specificity for the differentiation blocking activity of carcinoembryonic antigen resides in its glycophosphatidyl-inositol anchor.

Authors:  R A Screaton; L DeMarte; P Dráber; C P Stanners
Journal:  J Cell Biol       Date:  2000-08-07       Impact factor: 10.539

Review 7.  The glycosylphosphatidylinositol anchor: a complex membrane-anchoring structure for proteins.

Authors:  Margot G Paulick; Carolyn R Bertozzi
Journal:  Biochemistry       Date:  2008-06-17       Impact factor: 3.162

8.  Identification of a Golgi GPI-N-acetylgalactosamine transferase with tandem transmembrane regions in the catalytic domain.

Authors:  Tetsuya Hirata; Sushil K Mishra; Shota Nakamura; Kazunobu Saito; Daisuke Motooka; Yoko Takada; Noriyuki Kanzawa; Yoshiko Murakami; Yusuke Maeda; Morihisa Fujita; Yoshiki Yamaguchi; Taroh Kinoshita
Journal:  Nat Commun       Date:  2018-01-26       Impact factor: 14.919

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.